Drug
Dalteparin (Fragmin®)
Dalteparin (Fragmin®) is a pharmaceutical drug with 4 clinical trials. Historical success rate of 25.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
25.0%
Based on 1 completed trials
Completion Rate
25%(1/4)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
3(75%)
Phase Distribution
Ph phase_2
1
25%
Ph phase_4
3
75%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
3(75.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
25.0%
1 of 4 finished
Non-Completion Rate
75.0%
3 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(1)
Terminated(3)
Detailed Status
Terminated3
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
25.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 43 (75.0%)
Trials by Status
terminated375%
completed125%
Recent Activity
0 active trials
Showing 4 of 4
terminatedphase_2
Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients
NCT00041782
completedphase_4
Coagulation Profile in Patients Undergoing Video Assisted Thorascopic Surgery (VATS) for Lung Cancer
NCT01741506
terminatedphase_4
Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome
NCT00435487
terminatedphase_4
Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients
NCT00445328
Clinical Trials (4)
Showing 4 of 4 trials
NCT00041782Phase 2
Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients
NCT01741506Phase 4
Coagulation Profile in Patients Undergoing Video Assisted Thorascopic Surgery (VATS) for Lung Cancer
NCT00435487Phase 4
Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome
NCT00445328Phase 4
Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4